KINJEL PATEL: Open Payments
NPI 1831860105 · SOMERSET, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$902 in 52 payments from 19 companies in 2025. Trend: 2023 $824 · 2024 $853 · 2025 $902
Food & beverage: $902
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $161 |
| Amgen Inc. | 7 | $109 |
| Eisai Inc. | 4 | $73 |
| Sumitomo Pharma America, Inc. | 4 | $72 |
| Lilly USA, LLC | 4 | $68 |
| SANOFI PASTEUR INC. | 3 | $67 |
| PFIZER INC. | 3 | $52 |
| Exact Sciences Corporation | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $34 |
Products named: BREZTRI, Repatha, Leqembi, FARXIGA, GEMTESA, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, JARDIANCE, Cologuard Collection Kit.
Industry payments across NJ — which companies pay providers there.
